Viewing Study NCT00875667

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-02-01 @ 7:34 PM
Study NCT ID: NCT00875667
Status: COMPLETED
Last Update Posted: 2019-09-16
First Post: 2009-04-01
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mantle Cell Lymphoma View
None Lymphoma, Mantle-Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mantle Cell Lymphoma View
None Relapsed Mantle Cell Lymphoma View
None Refractory Mantle Cell Lymphoma View
None Lymphoma View
None MCL View